VIR BIOTECHNOLOGY, I

VIR
Real-time Estimate Quote. Real-time Estimate  - 06/24 04:45:13 pm
49.61USD +5.33%

VIR BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

05/06/2021 | 04:32pm

Item 2.02 Results of Operations and Financial Condition.



On May 6, 2021, Vir Biotechnology, Inc. (the "Company") issued a press release
announcing its financial results for the quarter ended March 31, 2021. A copy of
the press release is attached hereto as Exhibit 99.1 and is incorporated herein
by reference.



The information in this Item 2.02, including the attached Exhibit 99.1, is being
furnished and shall not be deemed "filed" for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference into any filing made by the Company under the Securities Act of
1933, as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.





Item 9.01 Financial Statements and Exhibits.



(d) Exhibits

Exhibit No. Description
99.1 Press Release of the Company, dated May 6, 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)







--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

© Acquiremedia 2021
Copier lien
All news about VIR BIOTECHNOLOGY, INC.
8h ago
3d ago
3d ago
3d ago
3d ago